Giulia Ferrannini

Om mig
Publikationer
Populärvetenskap och samverkan

Om mig

Forskning:
2026-2027: ALF postdok Region Stockholm
2023-2025: postdok forskare, kardiologi, Medicin Solna, Karolinska Institutet.
21 april 2023: Disputation med avhandling “Dysglycaemia and
cardiovascular disease. Aspects on screening, management and prognosis.”
2020 - 2023: PhD, kardiologi, Medicin Solna, Karolinska Institutet.
Klinisk tjänstgöring:
2025-pågående: Biträdande överläkare Internmedicin, VO Geriatrik-Internmedicin,
Södertälje sjukhus.
2022 - 2025: Specialistläkare Internmedicin, VO Internmedicin,
Södertälje sjukhus.
2021 - 2022: Läkare, geriatriekn, Löwenströmska sjukhus.
2014 – 2019: ST-läkare Internmedicin, Universitá di Torino,
Italien
2007 – 2013: Läkarutbildning, Universitá di Modena e Reggio Emilia, Italien

Artiklar

Journal article: DIABETES OBESITY & METABOLISM. 2026
α-Hydroxybutyrate Association With Incident Type 2 Diabetes Over 10 Years Across Different Glycemic States
Fortin E; Norhammar A; Stadler D; Herzog PL; Ferrannini G; Ferrannini E
Journal article: CARDIOVASCULAR DIABETOLOGY. 2026;25(1):212
Effect of empagliflozin on copeptin levels in patients with recent acute coronary syndrome and newly detected dysglycaemia: a post-hoc analysis of the SOCOGAMI randomized controlled trial
Fortin E; Melander O; Ferrannini G; Nasman P; Norhammar A; Ryden L; Smetana S; Svensson M; Mellbin L
Journal article: ESC HEART FAILURE. 2026;13(4):xvag196
Association between chronic kidney disease and heart failure across the ejection fraction spectrum: a retrospective case-control study from the Swedish Heart Failure Registry
Valente V; Benson L; Corovic Cabrera C; Scorza R; Lindberg F; Haugen Lofman I; Melin M; Lund LH; Ferrannini G; Savarese G
Journal article: EUROPEAN JOURNAL OF HEART FAILURE. 2026;28:xuag193.823
Type 2 diabetes and chronic kidney disease combinations in heart failure across the ejection fraction spectrum: clinical associations, medication use, and cause-specific outcomes
Ferrannini G; Pol T; Ljugman C; Dahlstrom U; Merolla A; Lund LH
Article: HEART. 2026;:heartjnl-2025-327697
Defibrillation of persistent shockable rhythms and survival after in-hospital cardiac arrest
Sidebottom DB; Jonsson M; Nordkvist EB; Harrysson L; Magnusson C; Thoren A; Claesson A; Ferrannini G; Awad A; Riva G
Article: EUROPEAN HEART JOURNAL-QUALITY OF CARE AND CLINICAL OUTCOMES. 2026;:qcag063
Implementation of sodium-glucose co-transporter 2 inhibitors use in patients with heart failure across the ejection fraction: data from the Swedish heart failure registry
Ferrannini G; Musella F; Benson L; Valente V; Lindberg F; Boccalatte M; Cabrera CC; Dahlstrom U; Lund LH; Stolfo D; Savarese G
Article: EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY. 2026;33(1):64-77
Pharmacological treatment patterns and outcomes according to the coexistence of heart failure and Type 2 diabetes: data from the Swedish Heart Failure Registry and National Diabetes Registry
Musella F; Ferrannini G; Benson L; Gudbjornsdottir S; Guidetti F; Boccalatte M; Sibilio G; Orsini N; Eloranta S; Cabrera CC; Scorza R; Lund LH; Savarese G
Article: CARDIOVASCULAR DIABETOLOGY. 2025;24(1):452
Impact of type 2 diabetes on the relationship between chronic kidney disease and cardiovascular outcomes in heart failure across ejection fraction: observational study from the Swedish heart failure and the Swedish National diabetes registries
Merolla A; Valente V; Basile C; Benson L; Cosentino F; Dahlstrom U; Gudbjornsdottir S; Rovere-Querini P; Lund LH; Savarese G; Ferrannini G
Article: JACC-HEART FAILURE. 2025;13(11):102662
Iron Deficiency Definitions in Heart Failure Across Ejection Fraction Phenotypes Prevalence, Symptoms, and Cause-Specific Outcomes
Lindberg F; Cabrera CC; Benson L; Loefstroem U; Lindmark K; Hage C; Ferrannini G; Ljungman C; Von Haehling S; Butler J; Cleland JGF; Anker SD; Lund LH; Savarese G
Article: JACC-HEART FAILURE. 2025;13(8):102491
Etiology of Heart Failure Across the Ejection Fraction Spectrum and Association With Prognosis
Kozman K; Ferrannini G; Benson L; Dahlstroem U; Hage C; Savarese G; Shahim B; Lund LH
Article: POLISH ARCHIVES OF INTERNAL MEDICINE-POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ. 2025;135(6):17006
Direct oral anticoagulants versus vitamin-K antagonists in patients with single or double-positive antiphospholipid syndrome: a systematic review and meta-analysis
Nicoletto M; Ferrannini G; Galli E; Grosso A; Camerlo S; Bulai F; Marchisio A; Pomero F
Article: EUROPEAN JOURNAL OF HEART FAILURE. 2025;27(2):236-248
Characterizing atrial fibrillation in patients with and without heart failure across the ejection fraction spectrum: Incidence, prevalence, and treatment strategies
Valente V; Ferrannini G; Benson L; Gatti P; Guidetti F; Melin M; Braunschweig F; Linde C; Dahlstrom U; Lund LH; Fudim M; Savarese G
Article: JOURNAL OF CLINICAL PERIODONTOLOGY. 2025;52(1):16-23
Does Periodontitis Increase the Risk for Future Cardiovascular Events? Long-Term Follow-Up of the PAROKRANK Study
Norhammar A; Naesman P; Buhlin K; de Faire U; Ferrannini G; Gustafsson A; Kjellstrom B; Kvist T; Jaghagen EL; Lindahl B; Nygren A; Naslund U; Svenungsson E; Klinge B; Ryden L
Article: JCI INSIGHT. 2024;9(24):e180637
Fasting substrates predict chronic kidney disease progression in CREDENCE trial patients with type 2 diabetes
Ferrannini E; Baldi S; Scozzaro MT; Ferrannini G; Hansen MK
Article: LANCET DIABETES & ENDOCRINOLOGY. 2024;12(11):790-798
Dysglycaemia screening and its prognostic impact in patients with coronary artery disease: experiences from the EUROASPIRE IV and V cohort studies
Ferrannini G; Tuomilehto J; De Backer G; Kotseva K; Mellbin L; Schnell O; Wood D; De Bacquer D; Ryden L
Article: EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY. 2024;10(4):296-306
Glucagon-like peptide-1 receptor agonists use and associations with outcomes in heart failure and type 2 diabetes: data from the Swedish Heart Failure and Swedish National Diabetes Registries
Wallner M; Biber ME; Stolfo D; Sinagra G; Benson L; Dahlstrom U; Gudbjornsdottir S; Cosentino F; Mol PGM; Rosano GMC; Butler J; Metra M; Lund LH; Ferrannini G; Savarese G
Article: FRONTIERS IN CARDIOVASCULAR MEDICINE. 2024;11:1385281
The management of heart failure in Sweden-the physician's perspective: a survey
Ferrannini G; Biber ME; Abdi S; Stahlberg M; Lund LH; Savarese G
Article: ESC HEART FAILURE. 2024;11(2):759-771
N-terminal pro-B-type natriuretic peptide concentrations, testing and associations with worsening heart failure events
Ferrannini G; Benson L; Lautsch D; Dahlstroem U; Lund LH; Savarese G; Carrero JJ
Article: DIABETES CARE. 2024;47(2):246-251
High Mannose Correlates With Surrogate Indexes of Insulin Resistance and Is Associated With an Increased Risk of Cardiovascular Events Independently of Glycemic Status and Traditional Risk Factors
Fortin E; Campi B; Ferrannini E; Mari A; Mellbin LG; Norhammar A; Naesman P; Ryden L; Saba A; Ferrannini G
Article: CARDIOVASCULAR DIABETOLOGY. 2024;23(1):25
Sex differences in the association between insulin resistance and non-fatal myocardial infarction across glycaemic states
Riccio A; Fortin E; Mellbin L; Norhammar A; Naesman P; Ryden L; Sesti G; Ferrannini G
Visa fler

Alla övriga publikationer

Preprint: RESEARCH SQUARE. 2026
Copeptin Response to Empagliflozin in Patients with Recent Acute Coronary Syndrome and Newly Detected Dysglycaemia: a post-hoc analysis of the SOCOGAMI randomized controlled trial
Fortin E; Melander O; Ferrannini G; Näsman P; Norhammar A; Rydén L; Smetana S; Svensson M; Mellbin L
Conference publication: EUROPEAN HEART JOURNAL. 2025;46
Blood pressure reduction through stair-walking, rationale and design of the HYPERWALK trial
Zavalis EA; Ebrahimi D; Norrbom J; Kenne E; Scorza R; Ferrannini G; Sundberg CJ; Andell P
Conference publication: EUROPEAN HEART JOURNAL. 2025;46
Early rhythm control in patients with acute decompensated heart failure
Kriz M; Kellner C; Beer B; Sundermeyer J; Dettling A; Besch L; Benesch-Vidal ML; Becher N; Ferrannini G; Savarese G; Kirchhof P; Blankenberg S; Magnussen C; Schrage B; Becher PM
Conference publication: EUROPEAN JOURNAL OF HEART FAILURE. 2025;27:69
Refining definitions of severe and advanced heart failure: insight from the swedish heart failure registry to optimize trial design and improve referral to advanced therapies
Guidetti F; Lund LH; Benson L; Hage C; Lindberg F; Basile C; Villaschi A; Ferrannini G; Musella F; Stolfo D; Scorza R; Baudry G; Valente V; Savarese G
Conference publication: DIABETOLOGIA. 2024;67:S475-S476
Screening for previously unknown dysglycaemia and its prognostic impact in patients with coronary artery disease; results from the EUROASPIRE programme
Ferrannini G; Tuomilehto J; De Backer G; Kotseva K; Mellbin L; Schnell O; Wood D; De Bacquer D; Ryden L
Conference publication: DIABETOLOGIA. 2024;67:S99-S100
The interaction between type 2 diabetes and chronic kidney disease on heart failure outcomes: observational study from the Swedish Heart Failure and the Swedish National Diabetes Registries
Merolla A; Valente V; Benson L; Dahlstrom U; Lund LH; Gudbjornsdottir S; Cosentino F; Savarese G; Ferrannini G
Conference publication: EUROPEAN JOURNAL OF HEART FAILURE. 2024;26:324-325
Pharmacological treatment patterns and outcomes according to the coexistence of heart failure and type 2 diabetes. Data from the Swedish Heart Failure Registry and National Diabetes Registry
Musella FF; Ferrannini G; Benson L; Dahlstrom U; Gudbjornsdottir S; Cosentino F; Guidetti F; Boccalatte M; Sibilio G; Rosano GMC; Lund LH; Savarese G
Conference publication: EUROPEAN JOURNAL OF HEART FAILURE. 2024;26:128
Etiology of heart failure across the ejection fraction spectrum and association with prognosis
Kozman KK; Ferrannini G; Benson L; Dahlstrom U; Hage C; Savarese G; Shahim B; Lund LH
Conference publication: EUROPEAN JOURNAL OF HEART FAILURE. 2024;26:8-9
Characterizing atrial fibrillation in patients with and without heart failure and across the ejection fraction spectrum: incidence, prevalence, and treatment strategies
Valente V; Ferrannini G; Gatti P; Guidetti F; Benson L; Lund LH; Melin M; Braunschweig F; Dahlstrom U; Fudim M; Savarese G
Conference publication: EUROPEAN JOURNAL OF HEART FAILURE. 2024;26:326-327
Insulin therapy in patients with heart failure and type 2 diabetes: predictors of use and associations with outcomes. Data from the Swedish Heart Failure Registry and National Diabetes Registry
Biber M; Rahimi A; Benson L; Cosentino F; Dahlstrom U; Gudbjornsdottir S; Lund L; Savarese G; Ferrannini G
Conference publication: EUROPEAN JOURNAL OF HEART FAILURE. 2024;26:369
Weight loss during hospitalization for heart failure while receiving intravenous loop diuretic is associated with lower risk of rehospitalization regardless BMI: data from the SwedeHF registry
Erhardsson M; Lund L; Benson L; Faxen UL; Ferrannini G; Savarese G; Dahlstrom U; Hage C
Study protocol: BMJ OPEN. 2024;14(3):e078983
Universal screening for early detection of chronic autoimmune, metabolic and cardiovascular diseases in the general population using capillary blood (UNISCREEN): low-risk interventional, single-centre, pilot study protocol
Merolla A; De Lorenzo R; Ferrannini G; Renzi C; Ulivi F; Bazzigaluppi E; Lampasona V; Bosi E
Preprint: RESEARCH SQUARE. 2023
Sex differences in the association between insulin resistance and myocardial infarction across glycaemic states
Riccio A; Fortin E; Mellbin L; Norhammar A; Näsman P; Rydén L; Sesti G; Ferrannini G
Conference publication: DIABETOLOGIA. 2023;66(SUPPL 1):S247
Sex differences in the association between insulin resistance indexes and myocardial infarction in individuals with different glycaemic states
Riccio A; Mellbin L; Norhammar A; Nasman P; Ryden L; Sesti G; Ferrannini G
Conference publication: DIABETOLOGIA. 2023;66(SUPPL 1):S243-S244
Empagliflozin improves insulin sensitivity in patients with a recent coronary syndrome and newly detected dysglycaemia
Ferrannini G; Fortin E; Mellbin L; Norhammar A; Nasman P; Smetana S; Ferrannini E; Ryden L
Conference publication: DIABETOLOGIA. 2023;66(SUPPL 1):S493
High mannose correlates with surrogate indexes of insulin resistance and predicts cardiovascular events independently of glycaemic status and traditional risk factors
Fortin E; Campi B; Ferrannini E; Mari A; Mellbin L; Norhammar A; Nasman P; Ryden L; Saba A; Ferrannini G
Editorial: EUROPEAN HEART JOURNAL. 2023;44(28):2557-2559
Risk prediction in patients with diabetes: is SCORE 2D the perfect solution?
Ryden L; Ferrannini G; Stand E
Conference publication: EUROPEAN JOURNAL OF HEART FAILURE. 2023;25:135-136
N-terminal pro-B-type natriuretic peptide concentrations, testing and associations with outcomes: an analysis of the swedish heart failure registry and the stockholm creatinine measurements cohorts
Ferrannini GG; Savarese G; Benson L; Lautsch D; Dahlstrom U; Lund L; Carrero JJ
Conference publication: EUROPEAN JOURNAL OF HEART FAILURE. 2023;25:21
Extremes of both weight gain and weight loss are associated with increased incidence of heart failure and cardiovascular death: evidence from the CANVAS Program and CREDENCE
Ferrannini GG; Pollock C; Natali A; Yavin Y; Mahaffey KW; Ferrannini E
Corrigendum: EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY. 2023;9(3):293
Association between use of novel glucose-lowering drugs and COVID-19 hospitalization and death in patients with type 2 diabetes: A nationwide registry analysis (Vol 9, pg 10, 2023)
Ferrannini G; Lund LH; Benson L; Rizzo M; Almahmeed W; Rosano GMC; Savarese G; Cosentino F
Visa fler

Om mig

Artiklar

Alla övriga publikationer

Nyheter från KI

Kalenderhändelser från KI